Guardant Health Investor Relations Material
Latest events
Q2 2025
Guardant Health
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Guardant Health Inc
Access all reports
Guardant Health, Inc. is a cancer-specific diagnostic company that provides blood tests, data sets, and analytics. The company's blood test detects cancer mutations in blood so that clinicians can prescribe medicines to match specific types of cancer. The company also provides its patient data sets and analytic tools to change the way hospitals model cancer outcomes. The company is based in Redwood City, California.
Key slides for Guardant Health Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Guardant Health Inc
Q2 2025
Guardant Health Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
GH
Country
🇺🇸 United States